English
简体中文
Total: £ 56.28
Published Date: 2024-04-10 | Pages: 103 | Tables: 219 | Medical Care
The global CRISPR Gene Detection and Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for CRISPR Gene Detection and Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Gene Detection and Diagnostic.
Report Scope
The CRISPR Gene Detection and Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPR Gene Detection and Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Gene Detection and Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Molecular Diagnostics
Sherlock Biosciences
Thermo Fisher Scientific Inc.
Aelian Biotechnology
Vivlion
Beckman Coulter Diagnostics
Binx Health
bioMérieux Diagnostics
Caspr Biotech
Agilent
Axxam
ERS Genomics
FASMAC
Illumina
Janssen Diagnostics
Locus Biosciences
Mammoth Biosciences
NRGene
Bio-Rad Laboratories, Inc
10x Genomics, Inc.
Segment by Type
Cutting Function Detection Method
Positioning Function Detection Method
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Gene Detection and Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cutting Function Detection Method
1.2.3 Positioning Function Detection Method
1.3 Market by Application
1.3.1 Global CRISPR Gene Detection and Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Gene Detection and Diagnostic Market Perspective (2019-2030)
2.2 CRISPR Gene Detection and Diagnostic Growth Trends by Region
2.2.1 Global CRISPR Gene Detection and Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRISPR Gene Detection and Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 CRISPR Gene Detection and Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 CRISPR Gene Detection and Diagnostic Market Dynamics
2.3.1 CRISPR Gene Detection and Diagnostic Industry Trends
2.3.2 CRISPR Gene Detection and Diagnostic Market Drivers
2.3.3 CRISPR Gene Detection and Diagnostic Market Challenges
2.3.4 CRISPR Gene Detection and Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Gene Detection and Diagnostic Players by Revenue
3.1.1 Global Top CRISPR Gene Detection and Diagnostic Players by Revenue (2019-2024)
3.1.2 Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global CRISPR Gene Detection and Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRISPR Gene Detection and Diagnostic Revenue
3.4 Global CRISPR Gene Detection and Diagnostic Market Concentration Ratio
3.4.1 Global CRISPR Gene Detection and Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Gene Detection and Diagnostic Revenue in 2023
3.5 CRISPR Gene Detection and Diagnostic Key Players Head office and Area Served
3.6 Key Players CRISPR Gene Detection and Diagnostic Product Solution and Service
3.7 Date of Enter into CRISPR Gene Detection and Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Gene Detection and Diagnostic Breakdown Data by Type
4.1 Global CRISPR Gene Detection and Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Type (2025-2030)
5 CRISPR Gene Detection and Diagnostic Breakdown Data by Application
5.1 Global CRISPR Gene Detection and Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRISPR Gene Detection and Diagnostic Market Size (2019-2030)
6.2 North America CRISPR Gene Detection and Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024)
6.4 North America CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Gene Detection and Diagnostic Market Size (2019-2030)
7.2 Europe CRISPR Gene Detection and Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024)
7.4 Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific CRISPR Gene Detection and Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Gene Detection and Diagnostic Market Size (2019-2030)
9.2 Latin America CRISPR Gene Detection and Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024)
9.4 Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Molecular Diagnostics
11.1.1 Roche Molecular Diagnostics Company Detail
11.1.2 Roche Molecular Diagnostics Business Overview
11.1.3 Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Introduction
11.1.4 Roche Molecular Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.1.5 Roche Molecular Diagnostics Recent Development
11.2 Sherlock Biosciences
11.2.1 Sherlock Biosciences Company Detail
11.2.2 Sherlock Biosciences Business Overview
11.2.3 Sherlock Biosciences CRISPR Gene Detection and Diagnostic Introduction
11.2.4 Sherlock Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.2.5 Sherlock Biosciences Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Detail
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Aelian Biotechnology
11.4.1 Aelian Biotechnology Company Detail
11.4.2 Aelian Biotechnology Business Overview
11.4.3 Aelian Biotechnology CRISPR Gene Detection and Diagnostic Introduction
11.4.4 Aelian Biotechnology Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.4.5 Aelian Biotechnology Recent Development
11.5 Vivlion
11.5.1 Vivlion Company Detail
11.5.2 Vivlion Business Overview
11.5.3 Vivlion CRISPR Gene Detection and Diagnostic Introduction
11.5.4 Vivlion Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.5.5 Vivlion Recent Development
11.6 Beckman Coulter Diagnostics
11.6.1 Beckman Coulter Diagnostics Company Detail
11.6.2 Beckman Coulter Diagnostics Business Overview
11.6.3 Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Introduction
11.6.4 Beckman Coulter Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.6.5 Beckman Coulter Diagnostics Recent Development
11.7 Binx Health
11.7.1 Binx Health Company Detail
11.7.2 Binx Health Business Overview
11.7.3 Binx Health CRISPR Gene Detection and Diagnostic Introduction
11.7.4 Binx Health Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.7.5 Binx Health Recent Development
11.8 bioMérieux Diagnostics
11.8.1 bioMérieux Diagnostics Company Detail
11.8.2 bioMérieux Diagnostics Business Overview
11.8.3 bioMérieux Diagnostics CRISPR Gene Detection and Diagnostic Introduction
11.8.4 bioMérieux Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.8.5 bioMérieux Diagnostics Recent Development
11.9 Caspr Biotech
11.9.1 Caspr Biotech Company Detail
11.9.2 Caspr Biotech Business Overview
11.9.3 Caspr Biotech CRISPR Gene Detection and Diagnostic Introduction
11.9.4 Caspr Biotech Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.9.5 Caspr Biotech Recent Development
11.10 Agilent
11.10.1 Agilent Company Detail
11.10.2 Agilent Business Overview
11.10.3 Agilent CRISPR Gene Detection and Diagnostic Introduction
11.10.4 Agilent Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.10.5 Agilent Recent Development
11.11 Axxam
11.11.1 Axxam Company Detail
11.11.2 Axxam Business Overview
11.11.3 Axxam CRISPR Gene Detection and Diagnostic Introduction
11.11.4 Axxam Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.11.5 Axxam Recent Development
11.12 ERS Genomics
11.12.1 ERS Genomics Company Detail
11.12.2 ERS Genomics Business Overview
11.12.3 ERS Genomics CRISPR Gene Detection and Diagnostic Introduction
11.12.4 ERS Genomics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.12.5 ERS Genomics Recent Development
11.13 FASMAC
11.13.1 FASMAC Company Detail
11.13.2 FASMAC Business Overview
11.13.3 FASMAC CRISPR Gene Detection and Diagnostic Introduction
11.13.4 FASMAC Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.13.5 FASMAC Recent Development
11.14 Illumina
11.14.1 Illumina Company Detail
11.14.2 Illumina Business Overview
11.14.3 Illumina CRISPR Gene Detection and Diagnostic Introduction
11.14.4 Illumina Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.14.5 Illumina Recent Development
11.15 Janssen Diagnostics
11.15.1 Janssen Diagnostics Company Detail
11.15.2 Janssen Diagnostics Business Overview
11.15.3 Janssen Diagnostics CRISPR Gene Detection and Diagnostic Introduction
11.15.4 Janssen Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.15.5 Janssen Diagnostics Recent Development
11.16 Locus Biosciences
11.16.1 Locus Biosciences Company Detail
11.16.2 Locus Biosciences Business Overview
11.16.3 Locus Biosciences CRISPR Gene Detection and Diagnostic Introduction
11.16.4 Locus Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.16.5 Locus Biosciences Recent Development
11.17 Mammoth Biosciences
11.17.1 Mammoth Biosciences Company Detail
11.17.2 Mammoth Biosciences Business Overview
11.17.3 Mammoth Biosciences CRISPR Gene Detection and Diagnostic Introduction
11.17.4 Mammoth Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.17.5 Mammoth Biosciences Recent Development
11.18 NRGene
11.18.1 NRGene Company Detail
11.18.2 NRGene Business Overview
11.18.3 NRGene CRISPR Gene Detection and Diagnostic Introduction
11.18.4 NRGene Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.18.5 NRGene Recent Development
11.19 Bio-Rad Laboratories, Inc
11.19.1 Bio-Rad Laboratories, Inc Company Detail
11.19.2 Bio-Rad Laboratories, Inc Business Overview
11.19.3 Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Introduction
11.19.4 Bio-Rad Laboratories, Inc Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.19.5 Bio-Rad Laboratories, Inc Recent Development
11.20 10x Genomics, Inc.
11.20.1 10x Genomics, Inc. Company Detail
11.20.2 10x Genomics, Inc. Business Overview
11.20.3 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Introduction
11.20.4 10x Genomics, Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024)
11.20.5 10x Genomics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cutting Function Detection Method
Table 3. Key Players of Positioning Function Detection Method
Table 4. Global CRISPR Gene Detection and Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global CRISPR Gene Detection and Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global CRISPR Gene Detection and Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global CRISPR Gene Detection and Diagnostic Market Share by Region (2019-2024)
Table 8. Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global CRISPR Gene Detection and Diagnostic Market Share by Region (2025-2030)
Table 10. CRISPR Gene Detection and Diagnostic Market Trends
Table 11. CRISPR Gene Detection and Diagnostic Market Drivers
Table 12. CRISPR Gene Detection and Diagnostic Market Challenges
Table 13. CRISPR Gene Detection and Diagnostic Market Restraints
Table 14. Global CRISPR Gene Detection and Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global CRISPR Gene Detection and Diagnostic Market Share by Players (2019-2024)
Table 16. Global Top CRISPR Gene Detection and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Detection and Diagnostic as of 2023)
Table 17. Ranking of Global Top CRISPR Gene Detection and Diagnostic Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by CRISPR Gene Detection and Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CRISPR Gene Detection and Diagnostic Product Solution and Service
Table 21. Date of Enter into CRISPR Gene Detection and Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CRISPR Gene Detection and Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Type (2019-2024)
Table 25. Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Type (2025-2030)
Table 27. Global CRISPR Gene Detection and Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Application (2019-2024)
Table 29. Global CRISPR Gene Detection and Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global CRISPR Gene Detection and Diagnostic Revenue Market Share by Application (2025-2030)
Table 31. North America CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 46. Roche Molecular Diagnostics Company Detail
Table 47. Roche Molecular Diagnostics Business Overview
Table 48. Roche Molecular Diagnostics CRISPR Gene Detection and Diagnostic Product
Table 49. Roche Molecular Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 50. Roche Molecular Diagnostics Recent Development
Table 51. Sherlock Biosciences Company Detail
Table 52. Sherlock Biosciences Business Overview
Table 53. Sherlock Biosciences CRISPR Gene Detection and Diagnostic Product
Table 54. Sherlock Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 55. Sherlock Biosciences Recent Development
Table 56. Thermo Fisher Scientific Inc. Company Detail
Table 57. Thermo Fisher Scientific Inc. Business Overview
Table 58. Thermo Fisher Scientific Inc. CRISPR Gene Detection and Diagnostic Product
Table 59. Thermo Fisher Scientific Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 60. Thermo Fisher Scientific Inc. Recent Development
Table 61. Aelian Biotechnology Company Detail
Table 62. Aelian Biotechnology Business Overview
Table 63. Aelian Biotechnology CRISPR Gene Detection and Diagnostic Product
Table 64. Aelian Biotechnology Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 65. Aelian Biotechnology Recent Development
Table 66. Vivlion Company Detail
Table 67. Vivlion Business Overview
Table 68. Vivlion CRISPR Gene Detection and Diagnostic Product
Table 69. Vivlion Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 70. Vivlion Recent Development
Table 71. Beckman Coulter Diagnostics Company Detail
Table 72. Beckman Coulter Diagnostics Business Overview
Table 73. Beckman Coulter Diagnostics CRISPR Gene Detection and Diagnostic Product
Table 74. Beckman Coulter Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 75. Beckman Coulter Diagnostics Recent Development
Table 76. Binx Health Company Detail
Table 77. Binx Health Business Overview
Table 78. Binx Health CRISPR Gene Detection and Diagnostic Product
Table 79. Binx Health Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 80. Binx Health Recent Development
Table 81. bioMérieux Diagnostics Company Detail
Table 82. bioMérieux Diagnostics Business Overview
Table 83. bioMérieux Diagnostics CRISPR Gene Detection and Diagnostic Product
Table 84. bioMérieux Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 85. bioMérieux Diagnostics Recent Development
Table 86. Caspr Biotech Company Detail
Table 87. Caspr Biotech Business Overview
Table 88. Caspr Biotech CRISPR Gene Detection and Diagnostic Product
Table 89. Caspr Biotech Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 90. Caspr Biotech Recent Development
Table 91. Agilent Company Detail
Table 92. Agilent Business Overview
Table 93. Agilent CRISPR Gene Detection and Diagnostic Product
Table 94. Agilent Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 95. Agilent Recent Development
Table 96. Axxam Company Detail
Table 97. Axxam Business Overview
Table 98. Axxam CRISPR Gene Detection and Diagnostic Product
Table 99. Axxam Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 100. Axxam Recent Development
Table 101. ERS Genomics Company Detail
Table 102. ERS Genomics Business Overview
Table 103. ERS Genomics CRISPR Gene Detection and Diagnostic Product
Table 104. ERS Genomics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 105. ERS Genomics Recent Development
Table 106. FASMAC Company Detail
Table 107. FASMAC Business Overview
Table 108. FASMAC CRISPR Gene Detection and Diagnostic Product
Table 109. FASMAC Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 110. FASMAC Recent Development
Table 111. Illumina Company Detail
Table 112. Illumina Business Overview
Table 113. Illumina CRISPR Gene Detection and Diagnostic Product
Table 114. Illumina Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 115. Illumina Recent Development
Table 116. Janssen Diagnostics Company Detail
Table 117. Janssen Diagnostics Business Overview
Table 118. Janssen Diagnostics CRISPR Gene Detection and Diagnostic Product
Table 119. Janssen Diagnostics Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 120. Janssen Diagnostics Recent Development
Table 121. Locus Biosciences Company Detail
Table 122. Locus Biosciences Business Overview
Table 123. Locus Biosciences CRISPR Gene Detection and Diagnostic Product
Table 124. Locus Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 125. Locus Biosciences Recent Development
Table 126. Mammoth Biosciences Company Detail
Table 127. Mammoth Biosciences Business Overview
Table 128. Mammoth Biosciences CRISPR Gene Detection and Diagnostic Product
Table 129. Mammoth Biosciences Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 130. Mammoth Biosciences Recent Development
Table 131. NRGene Company Detail
Table 132. NRGene Business Overview
Table 133. NRGene CRISPR Gene Detection and Diagnostic Product
Table 134. NRGene Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 135. NRGene Recent Development
Table 136. Bio-Rad Laboratories, Inc Company Detail
Table 137. Bio-Rad Laboratories, Inc Business Overview
Table 138. Bio-Rad Laboratories, Inc CRISPR Gene Detection and Diagnostic Product
Table 139. Bio-Rad Laboratories, Inc Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 140. Bio-Rad Laboratories, Inc Recent Development
Table 141. 10x Genomics, Inc. Company Detail
Table 142. 10x Genomics, Inc. Business Overview
Table 143. 10x Genomics, Inc. CRISPR Gene Detection and Diagnostic Product
Table 144. 10x Genomics, Inc. Revenue in CRISPR Gene Detection and Diagnostic Business (2019-2024) & (US$ Million)
Table 145. 10x Genomics, Inc. Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR Gene Detection and Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global CRISPR Gene Detection and Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Cutting Function Detection Method Features
Figure 4. Positioning Function Detection Method Features
Figure 5. Global CRISPR Gene Detection and Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global CRISPR Gene Detection and Diagnostic Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. CRISPR Gene Detection and Diagnostic Report Years Considered
Figure 11. Global CRISPR Gene Detection and Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global CRISPR Gene Detection and Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global CRISPR Gene Detection and Diagnostic Market Share by Region: 2023 VS 2030
Figure 14. Global CRISPR Gene Detection and Diagnostic Market Share by Players in 2023
Figure 15. Global Top CRISPR Gene Detection and Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Detection and Diagnostic as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by CRISPR Gene Detection and Diagnostic Revenue in 2023
Figure 17. North America CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America CRISPR Gene Detection and Diagnostic Market Share by Country (2019-2030)
Figure 19. United States CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe CRISPR Gene Detection and Diagnostic Market Share by Country (2019-2030)
Figure 23. Germany CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific CRISPR Gene Detection and Diagnostic Market Share by Region (2019-2030)
Figure 31. China CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America CRISPR Gene Detection and Diagnostic Market Share by Country (2019-2030)
Figure 39. Mexico CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa CRISPR Gene Detection and Diagnostic Market Share by Country (2019-2030)
Figure 43. Turkey CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia CRISPR Gene Detection and Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Roche Molecular Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 46. Sherlock Biosciences Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 47. Thermo Fisher Scientific Inc. Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 48. Aelian Biotechnology Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 49. Vivlion Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 50. Beckman Coulter Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 51. Binx Health Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 52. bioMérieux Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 53. Caspr Biotech Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 54. Agilent Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 55. Axxam Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 56. ERS Genomics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 57. FASMAC Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 58. Illumina Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 59. Janssen Diagnostics Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 60. Locus Biosciences Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 61. Mammoth Biosciences Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 62. NRGene Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 63. Bio-Rad Laboratories, Inc Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 64. 10x Genomics, Inc. Revenue Growth Rate in CRISPR Gene Detection and Diagnostic Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
